US EditionOne Study Shows that the Boosted Influenza Vaccine, Which Will Receive Galicians over 70, Lowers Income by 31.8%
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
The Galflu clinical trial, Galicia's pioneering project on high-burden influenza vaccine, demonstrated the efficacy of this dose by reducing hospitalizations by 31.8 percent compared to the standard vaccine. Antonio Gómez Caamaño, Conselleiro de Sanidade, presented at a press conference the results of the study, accompanied by the Director General of Public Health, Carmen Durán, and researcher Federico Martinón, responsible for the Genetics, Vac…
A clinical trial in Galicia shows that the medicine reduces the risk of pneumonia and cardiovascular events The article High load vaccine in front of the flu reduces a 31.8% of hospitalizations was first published in GCencia.
Sanidade ratifies the expansion of the target population for the high load dose and 'baraja' put an end to double vaccination flu-covid ...
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
